Ameriprise’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-88,984
| Closed | -$7.11M | – | 4025 |
|
|
2021
Q1 | $7.11M | Sell |
88,984
-217,130
| -71% | -$17M | ﹤0.01% | 2146 |
|
|
2020
Q4 | $24.1M | Sell |
306,114
-385,784
| -56% | -$22.6M | 0.01% | 1099 |
|
|
2020
Q3 | $30.4M | Buy |
691,898
+28,168
| +4% | +$1.39M | 0.01% | 859 |
|
|
2020
Q2 | $29.4M | Buy |
663,730
+154,275
| +30% | +$5.76M | 0.01% | 855 |
|
|
2020
Q1 | $18.3M | Sell |
509,455
-133,951
| -21% | -$7.62M | 0.01% | 991 |
|
|
2019
Q4 | $45.6M | Buy |
643,406
+99,028
| +18% | +$7.18M | 0.02% | 742 |
|
|
2019
Q3 | $40.7M | Buy |
544,378
+84,177
| +18% | +$7.14M | 0.02% | 761 |
|
|
2019
Q2 | $37.1M | Sell |
460,201
-44,377
| -9% | -$3.12M | 0.02% | 814 |
|
|
2019
Q1 | $33.8M | Sell |
504,578
-1,076
| -0.2% | -$81.5K | 0.02% | 845 |
|
|
2018
Q4 | $37.6M | Buy |
505,654
+49,458
| +11% | +$4.08M | 0.02% | 729 |
|
|
2018
Q3 | $41.6M | Buy |
456,196
+112,808
| +33% | +$10.7M | 0.01% | 841 |
|
|
2018
Q2 | $33.8M | Buy |
343,388
+76,928
| +29% | +$8.6M | 0.01% | 858 |
|
|
2018
Q1 | $29.7M | Sell |
266,460
-107,556
| -29% | -$12.1M | 0.01% | 916 |
|
|
2017
Q4 | $38.5M | Buy |
374,016
+1,157
| +0.3% | +$115K | 0.02% | 681 |
|
|
2017
Q3 | $35.1M | Sell |
372,859
-14,581
| -4% | -$1.15M | 0.02% | 697 |
|
|
2017
Q2 | $30.2M | Buy |
387,440
+70,848
| +22% | +$5.32M | 0.02% | 764 |
|
|
2017
Q1 | $25.4M | Buy |
316,592
+35,133
| +12% | +$2.79M | 0.01% | 865 |
|
|
2016
Q4 | $22.2M | Sell |
281,459
-79
| -0% | -$6.14K | 0.01% | 934 |
|
|
2016
Q3 | $22M | Sell |
281,538
-9,949
| -3% | -$722K | 0.01% | 884 |
|
|
2016
Q2 | $20M | Sell |
291,487
-10,190
| -3% | -$703K | 0.01% | 903 |
|
|
2016
Q1 | $21.5M | Sell |
301,677
-15,724
| -5% | -$987K | 0.01% | 860 |
|
|
2015
Q4 | $19.7M | Sell |
317,401
-13,424
| -4% | -$819K | 0.01% | 927 |
|
|
2015
Q3 | $18.8M | Sell |
330,825
-3,223
| -1% | -$171K | 0.01% | 972 |
|
|
2015
Q2 | $17.9M | Buy |
334,048
+55,255
| +20% | +$2.69M | 0.01% | 1094 |
|
|
2015
Q1 | $13.2M | Buy |
278,793
+10,314
| +4% | +$457K | 0.01% | 1329 |
|
|
2014
Q4 | $11.6M | Buy |
268,479
+12,226
| +5% | +$499K | 0.01% | 1388 |
|
|
2014
Q3 | $8.81M | Buy |
256,253
+13,710
| +6% | +$484K | 0.01% | 1583 |
|
|
2014
Q2 | $8.88M | Buy |
242,543
+43,764
| +22% | +$1.48M | 0.01% | 1645 |
|
|
2014
Q1 | $6.7M | Buy |
198,779
+66,386
| +50% | +$2.19M | ﹤0.01% | 1838 |
|
|
2013
Q4 | $4.49M | Sell |
132,393
-4,973
| -4% | -$172K | ﹤0.01% | 2050 |
|
|
2013
Q3 | $4.37M | Buy |
137,366
+5,778
| +4% | +$154K | ﹤0.01% | 2030 |
|
|
2013
Q2 | $2.97M | Buy |
+131,588
| New | +$2.85M | ﹤0.01% | 2174 |
|
Ameriprise's CMD Position: Q2 2021 in Review
Ameriprise sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 88,984 shares — an estimated $7.11M sold.
Ameriprise first reported a position in CMD in Q2 2013 and held it in 32 quarters. The position peaked at $45.6M in Q4 2019. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- Ameriprise reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- Ameriprise sold 88,984 Cantel Medical Corporation shares in Q2 2021, an estimated $7.11M.
- Ameriprise first reported a position in Cantel Medical Corporation in Q2 2013 and held it in 32 quarters.
- Ameriprise's Cantel Medical Corporation position peaked at $45.6M in Q4 2019.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on Ameriprise's 13F filing for Q2 2021, filed 16 Aug 2021.